Abstract
The blood coagulation system is a complicated cascade of reactions and feedback regulations that executes a rapid response to vascular injury, yet avoids occlusion of the vessel. There are several key components of this system in the regulation of blood clot propagation, such as antithrombin (AT), tissue factor pathway inhibitor (TFPI), thrombomodulin (TM) and protein C (PC), of which defect causes thromboembolic diseases. In recent years, targeted gene disruption technique by homologous recombination has been introduced to investigate the physiological roles of those natural anticoagulant molecules, not only in thrombogenesis but also in embyrogenesis. We have studied the natural anticoagulantion system in a decade, and recently established AT knockout mice as well as ryudocan (syndecan-4) knockout mice. Ryudocan is a cell surface heparan sulfate proteoglycan, which bears heparin-like glycosaminoglycan (heparan sulfate) cahins, orginally cloned from rat microvascular endothelial cells. We have demonstrated that ryudocan deficiency impairs the control of coagulation in fetal vessels of the placenta in mice. We have also reported that complete antithrombin deficiency in mice results in embryonic lethality, with severe fibrin deposition in the myocardium and the liver, accompanied with extensive subcutaneous hemorrhage. In this presentation, recent advances in understanding roles of natural anticoagulant molecules through the researches of targeted gene-knockout mice, including our experiences in antithrombin deficient mice and ryudocan deficient mice, will be discussed.
Similar content being viewed by others
References
Rosenberg RD, Aird WC. Vascular-bed-specific hemostatsis and hypercoagulable state.New Engl J Med. 1999;340:1555–1156.
Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.Proc Natl Acad Sci USA. 1995;92:850–854.
Huang ZF, Higuchi D, Lasky N, Broze GJ, Jr. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.Blood. 1997;90:944–951.
Jalbert LR, Rosen ED, Moons L, Chan JC, Carmeliet P, Collen D, Castellino FJ. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.J Clin Invest. 1998;102:1481–1488.
Ishiguro K, Kojima T, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality.J Clin Invest. 2000;106:873–878.
Yanada M, Kojima T, Ishiguro K, et al. The impact of antithrombin deficiency in thrombogenesis: LPS and stress-induced thrombus formation in heterozygous antithrombin deficient mice.Blood. 2002;99:2455–2458.
Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions.J Biol Chem. 2000;275:5249–5252.
Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth.Dev Dyn. 2000;219:539–544.
Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency increases susceptibility to kappa-carrageenan-induced renal damage.Lab Invest. 2001;81:509–516.
Ishiguro K, Kadomatsu K, Kojima T, et al. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice.J Biol Chem. 2001;276:47483–47488.
Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor.J Biol Chem. 1973;248:6490–6505.
Blajchman MA, Austin RC, Fernandez-Rachubinski F, Sheffield WP. Molecular basis of inherited human antithrombin deficiency.Blood. 1992;80:2159–2171.
Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.Annu Rev Cell Biol. 1992;8:365–393.
Kojima T, Shworak NW, Rosenberg RD Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.J Biol Chem. 1992;267:4870–4877.
Kojima T, Leone CW, Marchildon GA, Marcum JA, Rosenberg RD. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.J Biol Chem. 1992;267:4859–4869.
Berg DJ, Kuhn R, Rajewsky K, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.J Clin Invest. 1995;96:2339–2347.
Imai K, Takeshita A, Hanazawa S. Transforming growth factor-beta inhibits lipoplyssaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression.Infect Immun. 2000;68:2418–2423.
Author information
Authors and Affiliations
About this article
Cite this article
Kojima, T. Targeted gene disruption of natural anticoagulant proteins in mice. Int J Hematol 76 (Suppl 2), 36–39 (2002). https://doi.org/10.1007/BF03165083
Issue Date:
DOI: https://doi.org/10.1007/BF03165083